Consumer Health News and Research RSS Feed - Consumer Health News and Research

Future of drug information: via a mobile app? An interview with Dr Salvatore Volpe

Future of drug information: via a mobile app? An interview with Dr Salvatore Volpe

Whether prescribing or dispensing drugs to patients, or providing care to patients who are taking medications, drug information plays an essential role in every health professional’s busy day. [More]
Colorado state employees now have access to Paladina Health's family practice physicians

Colorado state employees now have access to Paladina Health's family practice physicians

Paladina Health, an innovative primary care approach to delivering individualized health care, announced today that State of Colorado employees and their eligible dependents who have health coverage through UnitedHealthcare now have access to Paladina Health's family practice physicians in Colorado. [More]
Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, has initiated SANET-ep, a Phase III sulfatinib (HMPL-012) registration trial in China in patients with extra-pancreatic neuroendocrine tumors ("NETs"), which are all non-pancreatic NETs, including, for example, NETs originating in the lymph, lung and across the gastrointestinal tract. [More]
Medical experts, business leaders to explore healthcare system at Digital Health Summit at CES 2016

Medical experts, business leaders to explore healthcare system at Digital Health Summit at CES 2016

The driving forces behind the exponential growth of the multi-billion dollar digital health space will be examined at the 7th annual Digital Health Summit, a Living in Digital Times production at CES 2016. [More]
Hutchison MediPharma begins sulfatinib Phase I trial in US

Hutchison MediPharma begins sulfatinib Phase I trial in US

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, has initiated the Phase I clinical trial of sulfatinib (HMPL-012) in the United States. [More]
Vomaris signs exclusive global commercial partnership with Metrex for Procellera Antimicrobial Wound Dressings

Vomaris signs exclusive global commercial partnership with Metrex for Procellera Antimicrobial Wound Dressings

Vomaris Innovations, Inc. announced today that it has entered into an exclusive global commercial partnership for its microcurrent generating wound care products, Procellera Antimicrobial Wound Dressings, for the Long Term Care market with Metrex, a professional consumables brand within Kavo Kerr Group, which is a member of the Danaher Corporation. [More]
Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China. [More]
New ASU-POSTECH collaboration aims to discover biological molecules for health care, renewable energy research

New ASU-POSTECH collaboration aims to discover biological molecules for health care, renewable energy research

The Biodesign Institute at Arizona State University and Pohang University of Science and Technology (POSTECH), Pohang, South Korea, have announced a partnership that will catalyze discoveries with a major impact on health care and clean energy applications. [More]
Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Communications professionals often are expected to be experts in all facets of the vast spectrum of communications, from brand, corporate, crisis and digital communications to corporate reputation and channel strategy and everything in between. [More]
Health Gorilla announces launch of expanded physician portal

Health Gorilla announces launch of expanded physician portal

Health Gorilla today announced the launch of its expanded physician portal, part of a new clinical network the company will unveil next month to connect doctors, vendors, and patients within a single, secure platform. [More]
Breakthrough initiative aims at empowering Americans to make better food choices

Breakthrough initiative aims at empowering Americans to make better food choices

Empowering Americans to make better food choices is the goal of a breakthrough initiative between the American Heart Association, the nation's largest voluntary organization dedicated to fighting heart disease and stroke, and Aramark, the largest U.S.-based food service provider. [More]
Two substantial gifts to support launch of integrative medicine program at Meridian Health

Two substantial gifts to support launch of integrative medicine program at Meridian Health

Riverview Medical Center Foundation is proud to announce two substantial gifts, totaling $10 million, which will significantly impact the way health care is delivered in our community. First, Joan and Robert Rechnitz, founders of the Two River Theater Company, donated $5 million to Riverview Medical Center Foundation to support the launch of an integrative medicine program. [More]
Welltok honors winners of inaugural Health Optimization Awards

Welltok honors winners of inaugural Health Optimization Awards

Welltok Inc., developer of the CafeWell Health Optimization Platform, today announced the winners of its inaugural Health Optimization Awards for Strategic Vision, Consumer Engagement and Health Innovation. The awards honor the extraordinary work of Magellan Health, the State of Colorado and Centura Health for their commitment to optimizing consumer health. [More]
Merck KGaA, Darmstadt, Germany forms Global Fertility Alliance with Illumina and Genea

Merck KGaA, Darmstadt, Germany forms Global Fertility Alliance with Illumina and Genea

Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced the formation of the Global Fertility Alliance, a new collaboration to advance excellence in fertility technologies and processes within the assisted reproductive treatment (ART) laboratory. [More]

DKSH supports Pfizer’s expansion to Laos

DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their businesses in Asia, has signed an agreement to provide marketing, sales, logistics, distribution, credit management and -collection services to Pfizer in Laos. [More]
Merck KGaA, Darmstadt, Germany granted FDA Fast Track designation for development of evofosfamide

Merck KGaA, Darmstadt, Germany granted FDA Fast Track designation for development of evofosfamide

Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced that the U.S. Food and Drug Administration has granted Fast Track designation for the development of evofosfamide (previously known as TH-302), administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally advanced unresectable pancreatic cancer. [More]

Validic raises $12.5 million Series B round led by Kaiser Permanente Ventures

Validic, the healthcare industry's leading digital health platform, announced today that it has secured a $12.5 million Series B round led by Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente. The funding will continue to fuel Validic's rapid growth. [More]
EMD Millipore launches Magna ChIRP RNA Interactome Kits for analyzing chromatin-associated RNAs

EMD Millipore launches Magna ChIRP RNA Interactome Kits for analyzing chromatin-associated RNAs

EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, Germany, today introduced Magna ChIRP™ RNA Interactome Kits, which allow researchers to more easily identify, recover and analyze regions of chromatin that interact with chromatin-associated RNAs such as long non-coding RNA (lncRNA). [More]
Validic adds MEDITECH to its global digital health ecosystem

Validic adds MEDITECH to its global digital health ecosystem

Validic, the healthcare industry's leading technology platform for accessing digital health data, announced today the addition of MEDITECH to its global digital health ecosystem. [More]
Merck Serono, Intrexon partner to develop and commercialize CAR-T cancer therapies

Merck Serono, Intrexon partner to develop and commercialize CAR-T cancer therapies

Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation, today announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. [More]
Advertisement